|
⚲
|
| Keyboard |
| Rovaldi Christopher
✚
|
|
|---|---|
| CIK # | 0001706040 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001706040] | |
| 4 | [0001706040] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Keros Therapeutics Inc | |
| Rovaldi Christopher | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Keros Therapeutics Inc KROS
Common Stock
|
2025-02-18 | Grant | 60,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Employee Stock Option (right to buy) · derivative
|
2024-02-13 | Grant | 150,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Employee Stock Option (right to buy) · derivative
|
2023-02-16 | Grant | 100,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-06 | Sell | 1,728 | $65.00 | 112,320 |
|
Keros Therapeutics Inc KROS
Employee Stock Option (right to buy) · derivative
|
2022-04-06 | Option exercise | 1,728 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-06 | Option exercise | 1,728 | $16.00 | 27,648 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Sell | 287 | $56.89 | 16,327 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Sell | 104 | $56.20 | 5,845 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Sell | 2 | $54.34 | 109 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Option exercise | 864 | $16.00 | 13,824 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Sell | 366 | $57.97 | 21,217 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-04-01 | Sell | 105 | $58.83 | 6,177 |
|
Keros Therapeutics Inc KROS
Employee Stock Option (right to buy) · derivative
|
2022-04-01 | Option exercise | 864 | $0.00 | |
|
Keros Therapeutics Inc KROS
Employee Stock Option (right to buy) · derivative
|
2022-02-01 | Grant | 100,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-04-03 | Sell | 2,900 | $38.27 | 110,983 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-04-03 | Sell | 600 | $39.02 | 23,412 |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2018-03-01 | Grant | 24,375 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-03-01 | Grant | 4,063 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-01-12 | Sell | 11,000 | $45.00 | 495,000 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-01-12 | Option exercise | 11,000 | $24.11 | 265,210 |
| showing 20 of 26 most recent transactions | |||||